Every cosmetic manufacturer, sooner or later, will be faced with a cosmeto-vigilance case. If there are sales, the undesirable effects will happen. It is therefore crucial to react to every case in an appropriate manner and for the Serious Undesirable Effects (SUE) to inform the relevant authorities – which is a legal obligation.
The Obelis team discuss the compliance regulations for personalized cosmetics products on the EU market. How to safely plan for creativity and innovation.
Find out more about the technical requirements and approval process for motor vehicles under EU regulation 2018/46/EC entering effect in September 2020.
Guidelines for the use and inclusion of cannabis and cannabidiol products within cosmetics on the EU market under EC regulation 1223/2009.
Preparations have begun for cosmetic compliance paths in the UK in the event of a no-deal Brexit. Learn more about new regulatory requirements with Obelis.
Products that assist and support individuals with disabilities, restricted mobility or other conditions to perform functions that would be difficult to perform without such products are known as ‘Assistive Technology’.Classifying these products is not an easy task as they might be a medical device or an ‘aid for daily living’. Read more about it.
An update of the regulatory impact of Brexit on cosmetics products on the EU and UK markets. Find out how Brexit will affect your product's compliance.
A simple guide to bringing your cosmetics products though the Cosmetics Products Notification Portal for total European Market compliance.
Minutes from meetings of the Scientific Committee on Consumer Safety (SCCS) are now public. Read about their discussions and opinions on cosmetic products.
A brief overview of the best path for ensuring full compliance with MDR 2017/745 and the implications it has for medical device manufacturers in Europe.